Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Lewis Joel
Relationship:  
City:   Norcross
State:   GA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   897,012    

Indirect Shares

  2,000      
Direct Value   $2,439,873    

Indirect Value

  $5,440      
Total Shares   899,012      
Total Value   $2,445,313      


Galectin Therapeutics Inc
 $2,439,873 Galectin Therapeutics Inc
 $2,439,873
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    2   
    0    

     Stock price went up :

    1   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   8.3%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Galectin Therapeutics Inc GALT 2024-04-24 897,012 2024-04-24 2,000    Premium*  
* Premium Members only  

Records found :    93         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2021-08-13 4 A $3.38 $16,667 D/D 4,931 248,784 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2021-08-31 4 A $3.93 $16,667 D/D 4,241 253,025 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-01-14 4 A $2.02 $16,667 D/D 8,251 307,868 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2020-11-13 4 A $2.75 $16,668 D/D 6,061 136,947 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2021-03-15 4 A $2.50 $16,668 D/D 6,667 194,324 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2021-04-30 4 A $4.42 $16,668 D/D 3,771 213,249 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2021-07-30 4 A $2.75 $16,668 D/D 6,061 243,853 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2021-09-30 4 A $3.88 $16,668 D/D 4,296 261,789 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2021-10-15 4 A $3.37 $16,668 D/D 4,946 266,735 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2021-11-15 4 A $2.86 $16,668 D/D 5,828 277,821 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2021-12-31 4 A $2.07 $16,668 D/D 8,052 299,617 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-02-28 4 A $1.87 $17,499 D/D 9,358 438 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-03-15 4 A $1.74 $17,499 D/D 10,057 448,000 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-04-15 4 A $1.74 $17,499 D/D 10,057 468,927 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-07-29 4/A A $2.26 $17,499 D/D 7,743 552,139 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-10-14 4 A $1.62 $17,499 D/D 10,802 627,720 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-02-15 4 A $2.07 $17,500 D/D 8,454 428,585 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-04-29 4 A $1.55 $17,500 D/D 11,290 480,217 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-05-13 4 A $1.36 $17,500 D/D 12,868 493,085 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-05-31 4 A $1.29 $17,500 D/D 13,566 506,651 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-06-30 4 A $1.31 $17,500 D/D 13,359 533,790 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-07-15 4 A $1.65 $17,500 D/D 10,606 544,396 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-09-30 4/A A $1.63 $17,500 D/D 10,736 616,918 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-10-31 4 A $1.38 $17,500 D/D 12,681 640,401 0 -
GALT Galectin Therapeutics Inc President and CEO   •       •      –    2022-11-15 4 A $1.24 $17,500 D/D 14,113 654,514 0 -

  93  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed